Allucent

Allucent is an asthma and allergy CRO offering trial design, regulatory strategy, and patient-centric solutions.

Allucent provides expert clinical development solutions for small to mid-sized biopharma, offering tailored services and strategic support.

Allucent excels in managing clinical trials, providing expert support for government and public health research with a focus on compliance and efficiency.

The company offers clinical development services from trial design to regulatory support.

Allucent’s case studies cover solutions in clinical pharmacology and regulatory strategy.

Allucent’s Expert Conversations series features video discussions on clinical pharmacology, dose optimization, oncology, and regulatory affairs.

Allucent’s guide offers insights and strategies for navigating drug development.

Allucent’s featured articles cover drug development, clinical trials, and industry trends for biotech professionals.

The page features news and developments at Allucent.

Pharm-Olam LLC. announces its successful expansion of clinical trial services into Kazakhstan.

HOUSTON, TEXAS – Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, announced today it has won six CRO Leadership Awards.

Allucent operates in more than 60 countries.

Allucent’s fellowship programs offer hands-on experience, mentorship, and industry insights for growth in clinical research.

Howard Brand, CFO at Allucent, has over 20 years of global CRO finance experience, driving growth and strategy in clinical research.

Kim Washburn, VP of Quality at Allucent, has over 25 years of expertise in regulatory compliance, clinical research and global quality strategy.

The company’s A-Team comprises leaders who address challenges in drug development.

Leslie DeVos, President of Regulatory & Drug Development Consulting at Allucent, has over 35 years of expertise in biotech and regulatory strategy and product development.

Allucent provides biopharmaceutical services and works to bring treatments to market.

Allucent is a global CRO that participates in events around the world.

Allucent, formed in 2022, combines expertise to spotlight biotech innovators and support small and mid-size biopharma in delivering treatments to patients.

The company helps small and mid-sized biotechs navigate drug development.

Allucent offers drug development solutions, clinical trials, and consulting through its global offices.

Allucent handles media inquiries and offers spokespeople and editorial content.

Contact Allucent, a full-service CRO for small to mid-sized biotech, for expert support, resources and guidance in drug development.

Allucent is a CRO serving small and mid-sized biotech companies, with services across the drug development pipeline.

Global contract research organization delivering CRO services, regulatory support, and clinical development solutions for biopharma.

Allucent’s Privacy Notice explains how the company collects, uses, stores, and safeguards personal data.

Allucent’s privacy practices cover investigators’ and site staff’s data and compliance with global data protection laws in clinical research.

Allucent protects personal data and complies with global privacy standards, including GDPR.

Allucent states its commitment to preventing modern slavery and maintaining ethical business practices across its operations and supply chain.